Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03369925 · ClinicalTrials.gov registry record · NA
Cognitive Effects of Citicoline in Men and Women With Age-Associated Memory Impairment
A NA study, sponsored by Kyowa Hakko Bio Co..
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03369925: Completed NA study, sponsored by Kyowa Hakko Bio Co..
NCT03369925 is a NA study that has completed, run by Kyowa Hakko Bio Co.. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03369925, a NA study, has completed, sponsored by Kyowa Hakko Bio Co..
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The objective of this trial is to determine the effects of citicoline on cognitive performance in healthy Men and Women with Age-Associated Memory Impairment compared to a placebo.
Interventions
- DIETARY_SUPPLEMENT Placebo supplement
- DIETARY_SUPPLEMENT Citicoline supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-01-02 |
| Est. Completion | 2018-12-03 |
| Phase | NA |
What the finished NCT03369925 record still lists
NCT03369925 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo supplement is the first listed.
NCT03369925 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03369925 about?
NCT03369925 is a clinical study titled "Cognitive Effects of Citicoline in Men and Women With Age-Associated Memory Impairment". The objective of this trial is to determine the effects of citicoline on cognitive performance in healthy Men and Women with Age-Associated Memory Impairment compared to a placebo.
What is the current status of trial NCT03369925?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2018-01-02. Estimated completion is 2018-12-03.
What interventions are being tested in trial NCT03369925?
The interventions under investigation include: Placebo supplement (DIETARY_SUPPLEMENT), Citicoline supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03369925?
This trial is sponsored by Kyowa Hakko Bio Co., which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03369925's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI